|
| |
ICU problems
Raised ICP and cerebral oedema
rapidly growing tumours usually lead to earlier and more serious
deterioration as a result of a decompensation of brain mechanisms that
normally control pressure within cranium. These tumours displace brain
structures along the paths of least resistance and from one intracranial
compartment to another: "herniation syndromes". Often fatal unless
rapidly treated
cerebral oedema of vasogenic type: responsive to steroids.
Dexamethasone
most commonly used steroid for the treatment of brain tumours. Minimal
mineralocorticoid effect. Compared to other treatments for
ICP onset is slow. Dose 16-40 mg/day in divided doses. Oral and IV doses are
the same
21-aminosteroids may provide anti-oedema effect of steroids without
associated glucocorticoid side effects
in brain tumour patients too rapid an infusion of mannitol may cause a
deterioration in neurological function by expanding vascular volume and hence
CBV. Pretreatment with 5-10 mg of frusemide may prevent this response
Tumour related hydrocephalus
Pathogenesis
results from obstruction of bulk flow of CSF along its normal route of
circulation or an overproduction of CSF relative to absorption (very rare)
tumour may block flow of CSF in ventricles or connecting channels within the
brain (foramina or aqueduct) causing non-communicating or obstructive
hydrocephalus or in the subarachnoid pathways causing communicating
hydrocephalus.
Diagnosis
presentation is with signs and symptoms of raised ICP
CT shows dilatation of ventricular system proximal to obstruction with
normal sized pathways distal to block (noncommunicating) or with dilatation of
all four ventricles (communicating)
Management
drainage (temporary/permanent)
treatment of tumour
Seizures
important cause of morbidity
approximately 40% of patient with glioma present with fits and 55% have at
least one episode by the time their tumour is diagnosed
classically cause focal fits but can cause almost any type
phenytoin first line treatment. Patients on dexamethasone frequently require
higher doses for therapeutic levels and seizure control. As steroid dose is
decreased phenytoin levels may become toxic. Cranial irradiation predisposes
some patients on anticonvulsants (especially phenytoin) to Stevens-Johnson and
erythema multiforme reactions
prophylactic anticonvulsants are not indicated for patients who have not had
fits. However may be indicated in the perioperative period (stop 7 days
post-op) or when ICP significantly elevated to prevent acute detioration
Complications of surgery
infection
haemorrhage
shunt obstruction
Complications of radiation
Stereotactic radiosurgery
seizures, nausea and vomiting at time of procedure occur occasionally. N
& V probably due to transient rise in ICP. Prophylactic anticonvulsants
and steroids commonly used
major late complication is focal radiation necrosis which can behave as an
expanding mass and mimic tumour progression. Can be distinguished from tumour
using PET scanning
Interstitial brachytherapy
haemorrhage, oedema and infection may result from catheter placement or
following removal
External beam radiotherapy
may result in early, or delayed symptomatic deterioration
early reactions primarily related to steroid-responsive oedema
Radiological appearances
Glioma
CT: solitary, irregular mass surrounded by oedema. Usually low density but
may be high or mixed. Mass effect usual. ± calcification (especially low
grade tumours). Most show partial enhancement; may involve only outer portion
resulting in "ring enhancement"
MRI: mass, often with adjacent oedema. Variety of signal intensities but in
general lower in signal intensity than normal brain on T1 weighted
images and higher on T2 weighted images
Metastases
CT: high or low density. Usually enhance. Often surrounded by substantial
oedema. Typically multiple. A single met cannot be distinguished from a glioma
by either CT or MRI
MRI: similar to CT
Meningioma
CT: arise from vault, falx or tentorium in characteristic sites the
commonest being the parasaggital region, over cerebral convexities and
sphenoid ridges. Slightly denser than brain due to calcium. Marked
enhancement. May be sclerosis and thickening of adjacent bone
MRI
Acoustic neuroma
enhance on both CT and MRI
Pituitary tumours
CT: pituitary adenoma may enhance vividly. Similar appearances may be seen
with large aneurysm, meningioma or craniopharyngioma
SXR: may be
enlargement or destruction of sella
Metastases
most frequently seen cerebral metastases are from lung and breast cancer.
Melanoma and systemic lymphoma also tend to spread to brain
Further reading
Fiandaca MS, Recht LD. Neurooncologic problems in the Intensive Care Unit. In
Rippe JM, Irwin RS, Fink MP, Cerra FB (eds), Intensive Care Medicine, 3rd ed.
Little Brown & Co., Boston, 1996, pp 2020-30
© Charles Gomersall December 1999
|